Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06273644

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Led by Nordlandssykehuset HF · Updated on 2026-03-27

50

Participants Needed

3

Research Sites

726 weeks

Total Duration

On this page

Sponsors

N

Nordlandssykehuset HF

Lead Sponsor

U

University of Oslo

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria). Aim: Investigate the diet's impact on tissue and serum glucose, plasma insulin, cytokine levels, amino acids, and gut microbiota in AIP, and their correlation with PBG (Porphobilinogen). Aim: Assess the diet's effect on AIP symptoms and health status in AIP. Aim: Measure the effect of a high-carbohydrate diet on mitochondrial activity in AIP Aim: Map and detect potential mutations in mitochondrial genomic DNA in AIP Aim: Discover new markers in AIP through RNA sequencing and machine learning. Participants will follow two diet plans, a 4-week intervention with 60-65 E% carbohydrates and a 4 week intervention with 40-45 E% carbohydrates.

CONDITIONS

Official Title

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of AIP
Not Eligible

You will not qualify if you...

  • Not having diagnosis of AIP
  • Undergoing treatment as part of other clinical research on AIP
  • Pregnancy
  • Diabetes
  • Below 18 years of age

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Nordland Hospital Trust

Bodø, Nordland, Norway, 8092

Actively Recruiting

2

Studieenheten, Akademiskt Specialistcentrum, Stockholm läns sjukvårdsområde, Region Stockholm

Stockholm, Sweden

Actively Recruiting

3

Norrland University Hospital

Umeå, Sweden

Actively Recruiting

Loading map...

Research Team

E

Elin Storjord, MD PhD

CONTACT

H

Hilde Thunhaug, Nurse

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here